A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Prograf (Tacrolimus, FK 506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-sparing Radical Prostatectomy.

Trial Profile

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Prograf (Tacrolimus, FK 506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-sparing Radical Prostatectomy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2010

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 May 2010 Results were presented at the 105th Annual Meeting of the American Urological Association.
    • 14 Oct 2008 Checked against ClinicalTrials.gov record, last updated 14 October 2008.
    • 01 Jan 2008 Planned patient number changed from 208 to 131 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top